Call for an instant quote 0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
19 September 2014 09:28
A trial to find a vaccine against the Ebola virus is due to take place at Oxford University
A trial to find a vaccine for the deadly Ebola virus is due to begin - and a volunteer from the UK will become the first person to receive the experimental drug.
A total of 60 people are due to take part in the safety trial at the University of Oxford, which may offer hope to people in Guinea, Sierra Leone, Liberia and other West African nations where Ebola has so far killed nearly 2,500 people.
More than half of those infected with the virus (53%) have died from the disease, according to the World Health Organisation - which should serve as a reminder for people travelling to Africa to take out medical travel insurance before they depart.
The vaccine, which is part of the current trial at Oxford, has been developed by GlaxoSmithKline (GSK) and the US National Institute of Health. It is aimed at the "Zaire strand" of the virus which is among those found in West Africa.
Experts at Oxford University have emphasised that participants cannot get infected with Ebola as the drug only contains one benign protein found in the virus.
The vaccine will only be tested on healthy adults, and researchers will check for possible side-effects and the nature of the immune response. It has already been tested on animals, and early indications are that it can protect non-human primates from Ebola without significant side effects.
GSK is producing 10,000 extra doses of the vaccine while the trial takes place thanks to a £2.8 million funding boost from the Medical Research Council, the Wellcome Trust and the Department for International Development
If the Oxford trial is a success, the vaccine will be tested again in West Africa to ensure the research takes differences between populations into account.
22 June 2018
The number of older people diagnosed with cancer is set to increase dramatically over the next 20 years, according to experts.
[more...]
21 June 2018
Patients value their relationship with a GP more importantly than surgery opening times, according to new research.
Only 3% of patients with the most common type of pancreatic cancer are living more than five years after being diagnosed, new analysis has shown.
19 June 2018
An England fan has urged supporters back home to head to Russia and experience the warm welcome he's been enjoying from locals.
14 June 2018
A new, low-cost portable device to help protect communities in Columbia from contaminated water has been developed by British engineers.
12 June 2018
As we near the opening match of football's grandest celebration on Thursday, fans are beginning to arrive in enthusiastic droves in Moscow.
09 June 2018
Scientists are trialling blood tests to find out the risk expecting mothers have of delivering prematurely.
08 June 2018
The Foreign and Commonwealth Office (FCO) has warned holiday-goers that some commonly-prescribed medicines are "controlled drugs" in certain countries.
A new lung cancer drug which is said to stretch life expectancy by a year is being introduced to the NHS.
06 June 2018
As pollen counts hit their highest level this week, hay fever sufferers are likely to suffer.
05 June 2018
Care home demanded to make improvements amid "serious concerns"
30 May 2018
Academics have announced their plans to examine suicide risk in men, as well as the ways to reduce it.